Autoantibodies to intracellular antigens are a hallmark of autoimmune disea
ses, although their role in disease pathogenesis is unclear. Centrosomes ar
e organelles involved in the organization of the mitotic spindle and they a
re targets of autoantibodies in systemic sclerosis (SSc). We used recombina
nt centrosome autoantigens, centrosome-specific antibodies, and immunoassay
s to demonstrate that a significant proportion of SSc patients exhibited ce
ntrosome reactivity. Two centrosome proteins cloned in our laboratory were
used to screen 129 SSc sera by Western blotting. The same sera were screene
d by immunofluorescence using centrosome-specific antibodies to distinguish
centrosomes from nuclear speckles commonly stained by SSc sera. Using thes
e criteria, 42.6% of SSc patients were autoreactive to centrosomes, a large
r percentage than reacted with all other known SSc autoantigens. Most centr
osome-positive sera reacted with both centrosome proteins and half were neg
ative for other routinely assayed SSe autoantibodies. By these criteria, we
have identified a novel class of SSe autoreactivity. Only a small percenta
ge of normal individuals and patients with other connective tissue diseases
had centrosome reactivity, These results demonstrate that centrosome autoa
ntibodies are a major component of autoreactivity in SSc and thus have pote
ntial in disease diagnosis. Centrosome autoantigens may be useful in studyi
ng the development of autoantibodies and chronic inflammation in SSc and pe
rhaps other autoimmune diseases.